Ayman Ismail

Title: Ayman Ismail: Innovator in Factor IX Fusion Proteins

Introduction

Ayman Ismail is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins that have applications in medicine.

Latest Patents

Ayman Ismail holds one patent titled "Factor IX fusion proteins and methods of making and using same." This groundbreaking invention provides Factor IX (FIX) fusion proteins that incorporate at least one heterologous moiety, such as an XTEN. The patent also outlines methods for creating and utilizing these FIX fusion proteins, thereby advancing therapeutic options for patients in need.

Career Highlights

Ayman currently works at Bioverativ Therapeutics Inc., where he leverages his expertise in protein engineering and biotechnology. His work at the company underscores his commitment to innovation in the healthcare sector, particularly in creating more effective treatments for bleeding disorders.

Collaborations

Throughout his career, Ayman has collaborated with notable coworkers such as Zhiqian Liu and Arjan Van Der Flier. These partnerships highlight the dynamic and collaborative environment at Bioverativ Therapeutics Inc., fostering advancements in the field of protein therapeutics.

Conclusion

Ayman Ismail's contributions to the development of Factor IX fusion proteins exemplify the vital role of inventors in advancing medical science. His work not only pushes the boundaries of biotechnology but also paves the way for innovative treatments that can significantly improve patient outcomes.